p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

• Matthias Gutekunst,

  Affiliation Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

  ⨯
• Moshe Oren,

  Affiliation Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

  ⨯
• Andrea Weilbacher,

  Affiliation Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

  ⨯
• Michael A. Dengler,

  Affiliation Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

  ⨯
• Christiane Markwardt,

  Affiliation Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

  ⨯
• Jürgen Thomale,

  Affiliation Institute for Cell Biology, University of Duisburg-Essen Medical School, Essen, Germany

  ⨯
• Walter E. Aulitzky,

  Affiliation 2nd Department of Internal Medicine, Robert-Bosch-Hospital, Stuttgart, Germany

  ⨯
• Heiko van der Kuip

  * E-mail: heiko.van-der-kuip@ikp-stuttgart.de

  Affiliation Dr Margarete-Fischer-Bosch Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, Germany

  ⨯